Live Analyst Rating Changes 1506 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Anderson Schock
BR
Anderson Schock
B. Riley Securities
Wall Street Analyst
★★★☆☆
#1016
on 13Foresight · ranked by our own returns
60%
Success Rate
-0.8%
Average Return
6 of 10 calls profitable · -8.6% vs benchmark
📈 Across the calls we could measure, roughly 60% of Anderson Schock's ratings turned a profit when each position was held for 1 year — averaging -0.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

25 Buy 5 Hold 0 Sell
Anderson's Stock Coverage 13 ratings · 2026-06-18
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
VREX
Varex Imaging
 May 28, 2026 BUY Strong Buy
+97.4% avg upside
9 analysts
$18.00
76.56% Upside
 ·
OBIO
Orchestra BioMed Holdings
 May 18, 2026 BUY Strong Buy
+241.9% avg upside
9 analysts
$10.00
158.41% Upside
 ·
OPRX
OptimizeRx
 May 13, 2026 BUY Strong Buy
+154.2% avg upside
9 analysts
$10.00
96.86% Upside
 +0.6%
ELMD
Electromed
 May 13, 2026 BUY Strong Buy
-13.0% avg upside
6 analysts
$40.00
7.61% Upside
 ·
TCMD
Tactile Systems Technology
 May 07, 2026 BUY Strong Buy
+58.8% avg upside
8 analysts
$36.00
39.44% Upside
 +1.1%
BEAT
HeartBeam
 Mar 31, 2026 BUY Buy
+487.7% avg upside
13 analysts
$4.00
458.38% Upside
 -35.5%
CLPT
ClearPoint Neuro
 Mar 18, 2026 BUY Strong Buy
+8.3% avg upside
7 analysts
$20.00
18.99% Upside
 +21.1%
XGN
Exagen
 Mar 11, 2026 BUY Strong Buy
+172.8% avg upside
10 analysts
$8.00
88.19% Upside
 +17.0%
SPOK
Spok Holdings
 Feb 26, 2026 HOLD Strong Buy
+66.5% avg upside
3 analysts
$14.00
35.77% Upside
 -4.8%
ANIK
Anika Therapeutics
 Feb 26, 2026 BUY Strong Buy
+38.2% avg upside
4 analysts
$18.00
26.48% Upside
 +17.4%
MBOT
Microbot Medical
 Feb 10, 2026 BUY Strong Buy
+258.1% avg upside
7 analysts
$5.00
165.98% Upside
 -16.6%
INGN
Inogen
 Jan 21, 2026 BUY Buy
+287.2% avg upside
7 analysts
$14.00
119.72% Upside
 +0.5%
INFU
InfuSystem Holdings
 Nov 05, 2025 BUY Strong Buy
+64.6% avg upside
7 analysts
$12.00
37.18% Upside
 -8.6%
🔒 8 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Anderson Schock — Frequently Asked Questions
How accurate are Anderson Schock's stock ratings?
Based on the calls 13Foresight could measure, about 60% of Anderson's ratings were profitable over a one-year hold, with an average return of -0.8% per rating, or -8.6% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Anderson ranked on 13Foresight?
Anderson Schock is currently ranked #1016 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Anderson cover?
Anderson most recently has ratings on VREX, OBIO, OPRX, ELMD, TCMD, BEAT, CLPT, XGN, SPOK, ANIK, MBOT, INGN and 1 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.